A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: A novel pharmacogenetic approach

Psychopharmacology Bulletin

Volumn 43, Issue 1, 2010, Pages 11-22

  Thomas, Kelan L H ^a   Ellingrod, Vicki L ^a   Bishop, Jeffrey R ^b   Keiser, Michael J ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADRB1; Adverse drug reactions; Beta 1 receptor; Pharmacogenetics; SSRI

Indexed keywords

ARGININE; BETA 1 ADRENERGIC RECEPTOR; DNA; FLUOXETINE; GLYCINE; PAROXETINE;

ADULT; ARTICLE; DEPRESSION; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC MARKER; GENOTYPE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; FLUOXETINE; GENE FREQUENCY; HEART RATE; HOMOZYGOTE; HUMANS; LINEAR MODELS; MALE; PAROXETINE; PHARMACOGENETICS; PHENOTYPE; PILOT PROJECTS; RECEPTORS, ADRENERGIC, BETA-1; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 78650896281     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Thomas KL, Ellingrod VL. Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions. Pharmacotherapy. 2009;29(7):822-831.
2. Keiser MJ, Setola V, Irwin JJ, et al. Predicting new molecular targets for known drugs. Nature. 2009;462(7270):175-181.
3. Bishop JR, Ellingrod VL, Akroush M, Moline J. The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives. Hum Psychopharmacol. 2009;24(3):207-215.
4. Richards B, Skoletsky J, Shuber AP, et al. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993;2(2):159-163. (Pubitemid 23075654)
5. Ronaghi M. Pyrosequencing for SNP genotyping. Methods Mol Biol. 2003;212:189-195.
6. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263-265. (Pubitemid 40202029)
7. Sandilands AJ, O'Shaughnessy KM. The functional significance of genetic variation within the betaadrenoceptor. Br J Clin Pharmacol. 2005;60(3):235-243. (Pubitemid 41224130)
8. Liu J, Liu ZQ, Yu BN, et al. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin Pharmacol Ther. 2006;80(1):23-32. (Pubitemid 43946840)
9. Hindmarch I, Kimber S, Cockle SM. Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance. Int Clin Psychopharmacol. 2000;15(6):305-318.
10. Michelson D, Fava M, Amsterdam J, et al. Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry. 2000;176:363-368.
11. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther. 2003;74(1):44-52. (Pubitemid 36776175)